CVS Health Corp (CVS)
Return on equity (ROE)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 4,614,000 | 8,344,000 | 4,311,000 | 7,910,000 | 7,179,000 |
| Total stockholders’ equity | US$ in thousands | 75,560,000 | 76,461,000 | 71,469,000 | 75,075,000 | 69,389,000 |
| ROE | 6.11% | 10.91% | 6.03% | 10.54% | 10.35% |
December 31, 2024 calculation
ROE = Net income ÷ Total stockholders’ equity
= $4,614,000K ÷ $75,560,000K
= 6.11%
The Return on Equity (ROE) for CVS Health Corp has shown fluctuations over the years. In 2020, the ROE was at 10.35%, which slightly increased to 10.54% in 2021. However, in 2022, there was a significant drop to 6.03%, indicating a decrease in the company's profitability relative to shareholders' equity. The following year, in 2023, there was a notable improvement as the ROE rose to 10.91%, suggesting a positive momentum in generating returns for shareholders. Subsequently, in 2024, there was a decrease to 6.11%, reversing the upward trend observed in the previous year. Overall, the variations in ROE reflect changes in the company's ability to generate profits from shareholders' equity, showing both positive and negative trends over the years.
Peer comparison
Dec 31, 2024